WAFD Stock News 21.34 05/13/2014 08:27:53 Washington Federal

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Washington Federal (WAFD) 21.34 $WAFD

Capitol Federal Falls Despite Earnings Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 30, 8:50AM CDT
Shares of Capitol Federal Financial (CFFN) fell 1.2% despite the company came out with better-than-expected fiscal second-quarter 2014 results.

Hudson City Earnings Beat Ests, Fall Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Apr 29, 11:04AM CDT
Hudson City Bancorp, Inc. (HCBK) reported yet another impressive quarter as it came out with first-quarter 2014 earnings of 9 cents per share, beating the Zacks Consensus Estimate by a penny.

First Niagara Q1 Earnings in Line, Shares Drop - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Apr 28, 10:10AM CDT
First Niagara (FNFG) reported first-quarter 2014 operating earnings of 17 cents per share, in line with the Zacks Consensus Estimate as well as the year-ago figure.

People's United Q1 Earnings Lag, Div Up - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 17, 9:50AM CDT
Regional bank People's United Financial Inc. reported first-quarter 2014 operating earnings per share of 19 cents, missing the Zacks Consensus Estimate by a penny.

Washington Federal Q2 Earnings in Line - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Apr 16, 8:10AM CDT
Washington Federal's second-quarter fiscal 2014 earnings (ended Mar 31) of 38 cents per share was in line with the Zacks Consensus Estimate. Moreover, the reported figure was up 11.8% from 34 cents in the prior-year quarter.

Washington Federal Announces Quarterly Earnings per Share Increase of 12%
PRWeb - Tue Apr 15, 7:15AM CDT
Washington Federal, Inc. (Nasdaq: WAFD), parent company of Washington Federal, today announced earnings of $38,657,000 or $.38 cents per diluted share for the quarter ended March 31, 2014, compared to $35,978,000 or $.34 cents per diluted share for the quarter ended March 31, 2013, an increase of 11.8%.

Should You Sell Washington Federal (WAFD) Before Earnings? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Apr 11, 7:48AM CDT
Washington Federal has a positive Earnings ESP and a Zacks Rank #3, suggesting that stock is poised to beat at the next earnings season.

Huntington to Strengthen Michigan Network - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 5:30PM CDT
Columbus, OH-based Huntington Bancshares Incorporated is set to strengthen its Michigan branch network by acquiring 11 branches in Central and East Michigan from Bank of America.

Washington Federal Continues with Inorganic Growth - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Mar 25, 9:00AM CDT
On March 24, 2014, we issued an updated research report on Washington Federal. The company has been growing and enhancing its market share inorganically.

Washington Federal Announces Brent Beardall Promoted to Chief Banking Officer and Diane Kelleher to Chief Financial Officer
GlobeNewswire - Tue Mar 25, 7:17AM CDT
via PRWEB - The Board of Directors of Washington Federal, Inc. (Nasdaq:WAFD), parent company of Washington Federal, today announced changes to its leadership team.

Washington Federal Declares Cash Dividend
GlobeNewswire - Mon Mar 24, 4:03PM CDT
via PRWEB - The Board of Directors of Washington Federal, Inc. (NASDAQ-WAFD), today announced a quarterly cash dividend of 10 cents per share. The dividend will be payable on April 18, 2014 to common stockholders of record on April 4, 2014. This will be Washington Federal's 125th consecutive quarterly cash dividend.

TFS Financial Shares Dip on In-Line Earnings - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 03, 8:00AM CST
Shares of TFS Financial fell 0.3% on Friday after the company reported fiscal first-quarter 2014 earnings on Jan 30 after market close. Earnings per share of 5 cents were in line with the Zacks Consensus Estimate.

Capitol Federal Financial Earnings Lag, Shares Dip - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 31, 8:40AM CST
Shares of Capitol Federal Financial dropped 0.3% on Thursday after the company's fiscal first-quarter 2014 earnings (ended Dec 31) of 12 cents per share missed the Zacks Consensus Estimate by a penny.

NY Community Bancorp Earnings Beat on Lower Expenses - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 30, 8:50AM CST
New York Community Bancorp, Inc. reported fourth-quarter 2013 cash earnings of 30 cents per share, which outpaced the Zacks Consensus of 27 cents.

First Niagara Reports Earnings as Expected - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 27, 8:00AM CST
First Niagara reported fourth-quarter 2013 cash earnings of 20 cents per share, which was in line with the Zacks Consensus Estimate.

Washington Federal Announces the Acquisition of 23 Branches in Arizona and Nevada
GlobeNewswire - Thu Jan 23, 7:50PM CST
via PRWEB - Washington Federal, Inc. (Nasdaq: WAFD), parent company of Washington Federal, today announced that Washington Federal has entered into an agreement with Bank of America to acquire 23 retail branches located in Arizona and Nevada. Washington Federal anticipates receiving approximately $610 million of deposits and $4 million of loans from the transaction. Subject to regulatory approval from the Office of the Comptroller of the Currency (OCC) and the satisfaction of customary closing conditions, the transaction is expected to close in the second calendar quarter of 2014. Additional details can be found in a Deposit Acquisition Summary in the Investor Relations section of Washington Federal's website at http://www.washingtonfederal.com.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

What to Expect: Your First Therapy Session Insights

Updated Category News Views 220

Starting With the Unknown: The Therapy Journey Begins Rolling into that first therapy session can feel like walking into a mystery with no clues. You're not alone if it stirs up some nerves—most folks feel the same, especially when it's your first rodeo in mental health support. That's where Cody Luke and David Spencer of Luke and Spencer Behavioral Health, based out in...

Continue Reading
CapCut's Role in AI-Assisted Small Biz Marketing

Updated Category News Views 0

In today's fast-paced digital world, small businesses lament the constant hustle to stay relevant online. This juggling act with limited resources often makes effective marketing feel like a high-wire circus performance. Enter AI tools, promising to lighten the load, and CapCut stands out as a game-changer. AI Tools Revolutionizing Small Business Marketing Amid growing...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 90

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
CSTS Unveils PremierX in NYC: A Bold Entertainment Move

Updated Category News Views 228

Welcome to the New Era of Entertainment Out of the blockbusters and into the open air, eh? On October 30, 2026, CSTS Enterprises flipped the New York skyline into a canvas for their grand kickoff of PremierXTM—a live entertainment brand poised to redefine how we gobble up our music, sport, and art. Now, there's a shot of adrenaline New Yorkers weren't exactly begging...

Continue Reading
Amgen's IMDELLTRA® Shows Promise in SCLC Battle

Updated Category News Views 408

Breakthrough Results in SCLC Treatment For years, small cell lung cancer (SCLC) has been the unruly beast in the oncology world, defying treatment advances and keeping survival rates stubbornly low. This nasty foe might just have met its match, folks. Amgen (NASDAQ:AMGN) announced results from their Phase 3 DeLLphi-305 trial that show their drug IMDELLTRA®, when teamed...

Continue Reading
TORRAS Cases Balance Protection with Slim Design for 2026

Updated Category News Views 39

Are Slim iPhone Cases Really Protecting Your Investment? Anyone who's dropped a brand-new phone knows the pain of watching your investment smack the concrete. But hey, welcome to 2026, where Consumer365's latest rundown on iPhone protective gear turns the spotlight on TORRAS. These folks grabbed attention with their Q3 Air and Q3 Air Pro cases, crafted for iPhone 18 Pro...

Continue Reading
Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 195

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Innovent's IBI3001 Shows Promise in Phase 1 Trials

Updated Category News Views 164

Pioneering Path with IBI3001 at ESMO 2026 Navigating through the crowded landscape of oncology trials, Innovent Biologics recently rolled out some riveting Phase 1 clinical data for their new darling, IBI3001. Top brass from Innovent took to the European Society for Medical Oncology (ESMO) Congress stage to lay bare their findings. Obviously, when you're presenting a...

Continue Reading
World Young Scientist Summit 2026 in Wenzhou Kicks Off

Updated Category News Views 208

Young Minds Meet AI Innovation Crack open the playbook, and it's clear: young brains from across the globe are gathering in Wenzhou, Zhejiang, China, to wrangle with AI and chart the course of science toward a sustainable future. The World Young Scientist Summit 2026 isn't just a parade of speeches and accolades. Nah, it's a deep dive into where innovative minds believe...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 237

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading

Top 5 Most Recently Viewed Articles

SoftBank Expands AI Infrastructure with DigitalBridge Deal

Updated Category News Views 109

SoftBank's Strategic Move in AI Infrastructure SoftBank Group Corp. has recently announced its plans to acquire DigitalBridge Group Inc. in a cash deal worth approximately $4 billion. This move is seen as a pivotal step in SoftBank's commitment to scaling its infrastructure capabilities for artificial intelligence globally. Details of the Acquisition Under the terms of...

Continue Reading
Nio's Bold Moves in the EV Space: What Investors Should Know

Updated Category News Views 158

Forget the Noise, Nio's Got a Game Plan Back in my day, when you heard whispers about a new product launch, it was either a cause for celebration or a catastrophe waiting to happen. Nio, the fast-rising EV player from China, is set to drop its ES9 SUV this May, and trust me, eyes are on the road. They’ve laid out the details like a clear roadmap. Mark Your Calendars Qin...

Continue Reading
Graycliff Partners Declares Landmark Structures Sale to Cerberus

Updated Category News Views 166

Graycliff Partners Announces the Sale of Landmark Structures Graycliff Partners LP has revealed its decision to sell Landmark Structures, an esteemed provider of water and industrial storage infrastructure solutions, to Cerberus Capital Management, a robust investment firm with a global reach. Landmark Structures specializes in designing, manufacturing, and installing...

Continue Reading
Wedbush Recognizes Uber Technologies as a Top Investment

Updated Category News Views 229

Wedbush Identifies Uber Technologies as a Prime Investment Opportunity In a recent analysis, Wedbush has included Uber Technologies Inc (NYSE: UBER) in its prestigious 'best ideas list.' This recognition stems from the company's attractive risk/reward dynamics, particularly as its shares are trading at a lower multiple. Valuation Insights Currently, Uber's stock is...

Continue Reading
Ververica Enhances Global Impact Through Innovative Partnerships

Updated Category News Views 161

Ververica's Global Influence in Real-Time Data Streaming Ververica, the pioneers behind Apache Flink®, recently highlighted its expanding global impact during the Flink Forward Jakarta event. This flagship occasion, known for focusing on cutting-edge data streaming technologies, served as an excellent platform for Ververica to demonstrate its dedication to helping...

Continue Reading